| Topic : The Role of IT in Health Care |
|
|
Healthcare & Life Sciences Professionals
|
Activity:
46 views;
last activity : 07 06 2010 20:18:09 +0000
|
|
|
|
1
Complexities
2
Too expensive
|
|||||||||||||
|
|
I believe this is the main reason, the healthcare sector makes minimum use of IT services because of its complexities.And even IT is subject to rapid change and usually the upgradation costs are quite high. In order to attain the goal of implementing ehealth services, IT and healthcare sector must go hand in hand. IT and healthcare industries going hand-in-hand will help equip the healthcare industry with much newer and upgraded technology. Making the healthcare-related software user-friendly would encourage the healthcare industry on the whole to go hi-tech. |
0
|
|
I have observed that low adoption rates of technologies and digital solutions in healthcare tend to be chiefly because of three reasons, 1) Technology is perceived as too hard to use or less than reliable in terms of uptime and connectivity; 2) It doesn't fit in well with workflow in healthcare environments; 3) It is too expensive to use and there is no clear return on investment (ROI) or way to measure ROI. |
0
|
|
|
Today, the "Right to education" law was passed. But, though the fundamental right promises one... |
|
|
265 referals
5 votes,
425 views
|
|
|
Patients across the country are being over charged by doctors and hospital's without being... |
|
|
25 referals
6 votes,
1616 views
|
|
|
PM Manmohan singh yesterday went on and said "you can't please all people. And the finance... |
|
|
1289 referals
40 arguments,
642 views
|
|
|
|
|
|
|
Technology is always essential for food revolution. This was observed during 1st green revolution also. It is the best way to get the qualitative products. Also, so far there is no proof of any severe problems from Bt brinjals. We can always give it a... |
The term GM foods(genetically-modified foods) is most commonly used to refer to crop plants created for human or animal consumption using the latest molecular biology techniques. These plants have been modified in the laboratory to enhance... |
In India, for Clinical trials, most of the MNC's dont have their analytical part of pharmacovigilance. At current stage PV is still into its preliminary stage in India and offshoring in this field has not yet reached the benchmark it has for clinical... |